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Abstract: Because of the highly unique structures of marine natural products, there are 
many examples of structures that were originally proposed based on spectral analyses but 
later proven incorrect. In many cases, the total syntheses of the originally proposed 
structures of marine natural products has confirmed their incorrectness and the subsequent 
total syntheses of the newly proposed structures proved the revised structures. This review 
will show such cases appearing after 2005 and demonstrate how the true structures were 
elucidated. 
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1. Introduction  
 
In the last several decades, research has expanded from land to ocean in order to find new leads for 
drug candidates. Because the ocean occupies almost 70% of Earth’s surface, it offers an unlimited 
possibility of biological and chemical diversities [1–3]. Given such a background, marine natural 
products chemistry has been progressing at an unprecedented rate, resulting in a multitude of 
discoveries of carbon skeletons and molecules hitherto unseen on land.
  
However, the sad truth is that structures originally proposed based on detailed modern spectral 
analyses often include misassignments. Because marine natural products often possess unusual 
structures, such as a large membered ring or a spiro-fused ring, they are prone to such misassignments 
and only synthetic studies could provide the correct structures. However, the total syntheses of marine 
natural products require extremely high level work in organic chemistry. The original purposes of the 
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total synthesis are to elucidate the absolute configuration, to develop effective synthetic routes that 
would supply materials for biological assays, or to take up the challenge of constructing complicated 
molecules. Nevertheless, synthetic organic chemists sometimes end up with incorrect structures of 
target molecules after multi-step stereoselective total syntheses. They must re-examine the original 
data of the compounds in order to deduce consistent structures and restart the synthesis to yield the 
true structures of natural product molecules. We had experienced an exciting series of synthetic studies 
on the antitumor compound pericosine A [4–8], which will be mentioned briefly later.  
Although there are many excellent reviews [9–13] of the synthesis of marine natural products, in 
2005, an excellent and encouraging review on misassignments and structural revisions was published 
by Nicolaou and Snyder [14]. It included a database of example cases as well as their own narrative of 
revisions of bioactive marine natural products diazonamide A and azaspiracid-1. Herein we will 
review recent synthetic studies of marine natural products that led to structural revisions after 2005 
except for palau’amine shown in Figure 1 [15], which has been described in another review [16].  
 
Figure 1. Proposed and revised structures of palau’amine. 
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2. Examples of Syntheses Leading to Structural Revisions of Marine Natural Products  
 
2.1. Macrocyclic Marine Natural Products 
 
Macrocyclic structure is one of the typical features of many marine natural products. Because of the 
large membered rings, macrocyclic marine natural products are highly flexible and this flexibility has 
made conformational analysis a difficult task.  
A cytotoxic depsipeptide designated as obyanamide (1) was isolated from the marine 
cyanobacterium Lyngbya confervoides, as shown in Scheme 1. Compared to related natural products, 
in the originally proposed structure 1  it had an unexpected (S)-configuration at C-3. The 
stereochemistry at C-3 in the Apa (aminopentanoic acid) part was deduced by chemical degradation 
and comparison of the hydrolyzated mixture with synthetic standards due to the limited amount of 
available material [17]. The total synthesis of 1 reported by Li and co-workers in 2005 is summarized 
in Scheme 1. Methyl (S)-N-Boc-3-aminopenatanoate (2), derived from (S)-2-aminobutyric acid via a 
Wolff rearrangement, was combined with ester 3 to afford amide 4. A Yamaguchi esterification 
between 4 and 5 afforded ester 6, which was cyclized to give the desired 1. But this total synthesis 
suggested the need for structural revision [18]. Since all other related compounds isolated from the 
Lyngbya species had R-configuration in the β-amino acid residues, the same research group thought 
the revised structure should be 7. Thus they carried out the total synthesis of 7 using the same strategy Mar. Drugs 2009, 7                                    
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with methyl (R)-N-Boc-3-aminopenatanoate (ent-2) derived from (R)-2-aminobutyric acid via a Wolff 
rearrangement, and proved that 7 is indeed the correct structure [19]. 
 
Scheme 1. Synthesis of proposed and revised structures of obyanamide. 
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The isolation of amphidinolide W (8), a new cytotoxic 12-membered macrolide from the 
dinoflagellate  Amphidinium  sp., was reported in 2002. The absolute configuration at C-6 was 
determined by the advanced Mosher’s method, utilizing the secondary alcohol that was obtained by 
degradation of the Baeyer-Villiger oxidation product of amphidinolide W [20]. Ghosh and co-workers 
synthesized proposed structure 8 via a Yamaguchi macrolactonization, as illustrated in Scheme 2. 
Chiral oxazolidone 9 was alkylated to 10 stereoselectively. Compound 10 was transformed into 8 via 
intermediate 11, showing that the structure of 8 did not match the reported data. Mar. Drugs 2009, 7                                    
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Scheme 2. Synthesis of proposed and revised amphidinolide W. 
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After a careful review of the 
1H-NMR spectra of natural amphidinolide W and the synthesized 
compound 8 , they found significant discrepancies between the chemical shifts in the C2-C11 ring 
region. Since they had synthesized 8 [(2S,6S)-isomer] and another epimer at C-2 [(2R,6S)-isomer] and 
neither of them corresponded to amphidinolide W, they hypothesized that the stereoisomer at C-6 12 
would be the revised structure. Then 12 was synthesized via intermediate 13 with ent-9 as a starting 
material. This total synhesis proved that 12 was the correct structure of amphidinolide W. In that study, 
they also synthesized another epimer at C-6, which is (2R,6R)-isomer [21,22].  
Palmerolide A is a macrolide isolated from the Atlantic tunicate Synoicum adareanum. It exhibits 
selective cytotoxicity to UACC-62 (melanoma), HCC-2998 (colon cancer), and RXF 393 (renal 
cancer) cell lines [23]. The relative stereochemistry of the originally proposed structure 14 was 
assigned on the basis of a combined analysis of coupling constants and the NOESY spectrum. The 
absolute configurations at C7 and C10 were assigned by the advanced Mosher’s method, as in the 
previous example. De Brabander and co-workers achieved the total synthesis of 14 via the Horner-
Wadsworth-Emmons olefination of C8 and C9 as a key step for macrocyclization as summarized in 
Scheme 3. Chiral vinyliodide 15 was coupled with borate 16, which was derived from D-arabitol, to 
afford alcohol 17. Then acid 18 was esterified with 17 to 19. After selective oxidation of primary 
hydroxyl group in 19, the resulted aldehyde was cyclized to 20 via H-W-E olefination. Methyl ester 20 
was transformed to azide 21, which was then converted into 14 via Curtius rearrangement followed by 
addition of 2-methylpropenylmagnesium bromide. As the data for 14 did not match that reported for 
the natural product, it was concluded that a structural revision was required. 
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Scheme 3. Synthesis of proposed and revised structures of palmerolide A. 
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After careful review of the NMR analysis of natural palmerolide A, De Brabander and co-workers 
thought that the relative stereochemistry C-10-C11 and C-19-C20 seemed reliable, but believed that 
the stereochemistry from C11 to C19 was doubtful. Then they set on next target 22 and carried out the 
total synthesis starting from ent-15. Since data of synthesized 22 was identical with those of 
palmerolode A except for the CD-spectrum, the correct structure of palmerolide A were determined 
and also the absolute configuration were elucidated [24]. A few months later, Nicolaou et al. reported 
the synthesis of 14 and naturally occurring enantiomer ent-22 via ring-closing metathesis, constructing 
the C8-C9 double bond as the key reaction [25,26]. 
The following two cases of dolastatin 19 and neopeltolide are quite similar. Both of them have a  
14-membered lactone fused to a pyran ring with the C3-C7 skeleton, as illustrated in Figure 2.  
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Figure 2. Structures of 14-membered lactone marine natural products. 
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Scheme 4. Synthesis of revised dolastatin 19. 
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Dolastatin (19) is a cancer cell growth inhibitor isolated from the sea hare Dolabella auricularia 
collected in the Gulf of California [27]. The initial stereostructure 23 was determined by careful 
spectral analysis. It must be noted that the presence of a NOESY cross peaks between H7/9-OMe in 
dolastatin (19) as illustrated in Figure 2 seems to contradict the revised structure 24. Paterson et al. 
proposed the revised structure 24 that has a different configuration on C5, C6, C7, and C13, through 
detailed conformational analysis of 
1H-NMR spectra and calculation of the lowest energy of the 
proposed molecule 23, and also through common bacterial biogenesis of related polyketides. The 
stereoselective total synthesis of 24 was achieved in 23 steps in 1.7% total yield as summarized in 
Scheme 4. An asymmetric Ti(O
iPr)4-(R)-BIBOL catalyzed aldol condensation between 27 and 28 
yielded 29. Aldehyde 30, that was derived from 29, was applied to a 1,4-syn boron mediated aldol Mar. Drugs 2009, 7                                    
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reaction with ketone 31 to give 32. After transformation of 32 to aldehyde 33, 33 was applied to 
another 1,4-syn boron mediated aldol reaction with ketone 31 to give β-hydroxyketone 34. Compound 
34 was treated with PPTS with trimethylorthoformate in MeOH to give 35 with a tetrahydropyran-ring 
formation and a methyl ether function. After transformation into carboxylic acid 36, 14-membered 
lactone 37 was formed via a Yamaguchi lactonization. This total synthesis was completed by coupling 
of  37 with fluoroalchohol 38 to afford desired 24, thereby elucidating the relative and absolute 
configurations [28].  
Neopeltolide derived from Neopeltidae sponge is a potent inhibitor of human cancer cell lines, such 
as A-549 and NCI-ADR-RES, and the P388 murine leukemia cell line [29]. Toward the end of 2007, 
Panek’s group and Scheidt’s groups reported independently the synthesis of neopeltolide, as shown in 
Scheme 5. Their accounts are quite similar.  
 
Scheme 5. Synthesis of neopeltolide. 
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After initial efforts to synthesize the proposed structure 25, Panek’s group set 26 as their next target 
based on close inspection of available spectral data and its structural homology to leucascandrolide A. 
The dihydropyran 41, which was formed by triflic acid promoted [4+2] annulations of aldehyde 39 
with allylsilane 40, was applied to a Yamaguchi macrolactonization. Stereoselective oxymercuration 
of the double bond in the dihydropyran moiety of the Yamaguchi lactonization product followed by 
acylation with bis(2,2,2-trifluoroethyl)phosphoacetic acid afforded phosphonoacetate 42. A   
Still-Gennari olefination between 42 and aldehyde 43 yielded 26. This total synthesis gave the correct 
relative and absolute configuration of neopeltolide [30].  
A few months after the report by Panek’s group, Scheidt and co-workers reported the synthesis and 
structural revision of neopeltolide. Like in Penek’s study, they synthesized 25 along the same route 
summarized in Scheme 6, starting from a coupling between alcohol fragment 44  and  dioxinone 
fragment 46 using a Yamaguchi esterification followed by the scandium(III) triflate catalyzed 
macrolactonization. Recognizing that 25 was not neopeltolide, they postulated the correct structure of 
26 and started the synthesis from a Yamaguchi esterification between alcohol fragment 45 and 46. Mar. Drugs 2009, 7                                    
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Macrolactonization of 47 using Sc(OTf)3 as a catalyst gave lactone 48, which was finally converted to 
26 via stereoselective NaBH4 reduction followed by a Mitsunobu reaction with carboxylic acid 49 [31]. 
The authors mentioned the difficulty of assigning the relative configuration of such a flexible 
macrocyclic natural product, whose originally proposed stereostructure around C9-C11-C13 in 25 was 
assigned from the NOESY cross peak between H9 and H11, as shown in Figure 2 [29]. 
 
2.2. Etheric Marine Natural Products 
 
Polyetheric or etheric compounds are well-known marine natural products. The isolation of 
brevenal from cultures of the dinoflagellate Karenia brevis, which is structurally related to 
hemibrevetoxin-B (50) but is almost half the size of the most well known metabolites of the same 
microorganisms called brevetoxins, was reported [32,33]. It is noteworthy that brevenal is not toxic to 
fish and antagonizes the toxic effects of brevetoxins in fish. 
 
Scheme 6. Total synthesis of brevenal. 
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Fuwa and co-workers attempted to perform the total synthesis of proposed structure 51 with their 
strategy of building a pentacyclic core via the advanced Suzuki-Miyaura coupling between AB and DE 
ring fragments as illustrated in Scheme 6. The common precursor of the DE fragment 52 was 
transformed into ketone 53, whose relative configuration was confirmed by the NOESY cross peak 
between H22/H27. Ketone 53 was stereoselectively methylated with methyllithium affording a 
diasteromeric mixture of alcohols in a 10:1 ratio. The NOESY cross peak between H27 and the methyl 
group at C26 suggested the stereochemistry of the major product 54, which was transformed into the 
initial DE fragment 55. Alkylborane prepared from 55 in situ coupled with the AB ring enol phosphate 
56 in the presence of Cs2CO3 and Pd(Ph)3. The coupled product gave desired 51 through multistep 
transformations; however, it was not identical with natural brevenal [34]. Then, the authors reviewed 
the NMR spectra of 51 and the natural product and found a significant deviation of the chemical shift 
values around C26 tertiary alcohol. In addition, there was no description in the literature [33] of NOEs 
between 26Me/H27 and 26Me/H28α,β, which were observed in the NOESY spectrum of 51. For the 
related marine natural product hemibrevetoxin-B (50), the configuration at C18, which corresponded 
to C26 in brevenal, was assumed by biosynthetic considerations [35].  
Then, Fuwa et al. postulated that natural brevenal (57) should be the epimer at C26 of 51 and 
restarted the synthesis of brevenal. The common precursor of the DE fragment 52 was transformed 
into ketone 58, and this was subjected to reductive cyclization with SmI2 to form a 7-membered ether 
ring with the desired stereochemistry in a mixture of lactone 59 (57%) and hydroxylether 60 (37%). 
The relative configuration of 59 was confirmed by NOESY analysis where cross peaks H22/H27 and 
26Me/H23 were observed. Both products 59 and 60 could be converted into the alternative DE 
fragment 61, which reacted with AB-ring enol phosphate 56 to afford the cross-coupled product. This 
finally yielded revised brevenal (57) via similar multiple sequences (Scheme 6) [36]. 
Elatenyne was isolated from the red alga Laurencia elata in 1986 and the proposed structure 62 is 
shown in Scheme 7 [37]. Isolation of structurely related natural product 63 from Laurencia majuscula 
was reported in 1993. The proposed structure was determined by NMR analysis and by comparison of 
spectral data with elatenyne [38]. Recently Burton and co-workers attempted to perform the total 
synthesis of elatenyne 62  and  63  as summarized in Scheme 7. The known bislactone 64 was 
transformed in to a mixture of anomeric acetate 65. Treatment of 65 with acidic methanol under reflux 
gave a mixture of 66, 67 and 68. Then the mixture was transformed solely into 69. Compound 69 was 
oxidized stereoselectively with dimethydioxirane to bis(epoxide) 70, that was then reacted with 
diallylmagnesium to give a diastereomeric mixture of bis(allylated)diols 71. The resulted inseparable 
mixture 71 was converted to separable alcohols 72 and 73. Purely isolated 73 led to desired 62 via 
Yamatoto-Peterson reaction from 74 to 75. 
In the same report 63 was synthesized from 73 via 77, which was prepared from aldehyde 76 by a 
Wittig reaction. But the data of 62 and 63 did not agree with those of natural products, suggesting both 
of them required structural revision [39,40]. The authors then reviewed the spectral data of reported 
natural products and synthesized 62 and 63 carefully, paying special attention to the 
13C-NMR 
chemical shift values at the ring juncture particularly pointed out in Scheme 7 and Figure 3. During the 
synthetic study of 62 and 63, they synthesized a large number of pyrano[3,2-b]pyrans and   
2,2’-bisfuranyl compounds and found that 
13C-NMR chemical shift values at the ring juncture fall into 
two distinct groups. When the δ value was larger than 76 ppm, the compound belongs to a   Mar. Drugs 2009, 7                                    
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2,2’-bisfuranyl-group, otherwise it belongs to a pyrano[3,2-b]pyran-group. The C-9 or C-10 chemical 
sifts values of synthesized 62 and 63 were δ 71.3, 71.4 ppm (for 62) and δ 73.9, 70.5 ppm (for 63). 
These evidences supported the structures of synthesized compounds 62 and 63. But natural elatenyne 
and the eneyne from L. majuscula had larger 
13C-NMR chemical shift values. In the original literatures 
13C-NMR chemical shift values for C-9 and C-10 of 62 and 63 were reported as δ 80.0 and 79.5 ppm 
for  62 and δ 79.2 and 77.9 ppm for 63  [37,38]. Therefore Burton and co-workers proposed the 
structures of elatenyne and the eneyne from L. majusculaas to be 78 and 79 respectively shown in 
Figure 3.  
 
Scheme 7. Synthesis of proposed structures of a metabolite from Laurencia sp. 
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Figure 3. Proposed and reproposed structures of elatenyne. 
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2.3. Other Examples 
 
Calafianin (80) (proposed structure), a spiroisoxazoline marine natural product, was isolated from 
the Mexican sponge Aplysina gerardogreeni. The relative configuration around the spiroisoxazoline 
moiety was deduced from NOE experiments, observing 2% enhancement of H7 signal when H1 was 
irradiated and 5% enhancement of H7 signal when H2 was irradiated [41]. The total synthesis of 
racemic  80  was conducted by Nishiyama’s group, as summarized in Scheme 8. Trans- and   
cis-piroisoxazolines 82, 83 was constructed as the key intermediate by oxidation of oximino-phenol 
affording  81 followed by reduction with Zn(BH4)2. Compound 80 was prepared from 83 via   
cis-epoxide 84 but the spectral data were not identical with those of the natural product. Applying the 
same reaction sequence to the trans-epoxide  85, which was derived from 82, furnished revised 
calafianin  86. It must be noted that synthesized 86, which had identical spectral data to natural 
calafianin, exhibited NOE correlation between H1 and H7 [42,43]. After the revision of the relative 
configuration of calafianin by Nishiyama’s group, the asymmetric synthesis for the assignment of  
(+)-calafianin was reported by Bardhan et al. [44]. 
 
Scheme 8. Synthesis of proposed and revised calafianin. 
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Tridachiahydropyrone, a structurally interesting fused bicyclic γ-dihydropyrone-containing natural 
product, was isolated from the Caribbean sacoglossan mollusc Tridachia crispata. Its stereochemistry 
was assigned as 87 as shown in Scheme 9 by NMR analysis. NOE experiments in particular suggested 
the cis-configuration between H9 and the 17-methyl group [45]. The total syntheses of proposed 
structure 87 and revised structure 88 were carried out by independent research groups, as summarized 
in Scheme 9. In order to determine the absolute configuration Perkins and co-workers synthesized 87. 
Compound 89 was reacted with cuprate 90 with cyclization affording cyclohexenol intermediate 91 
that was then stereoselectively methylated.  
The stereochemistry of the subsequent intermediate enone 92 was established by X-ray 
crystallography. The asymmetric total synthesis of 87 completed via a four-step process from 92 
confirmed that 87  was the incorrect structure [46]. In 2008, Moses and co-workers reported the 
racemic total synthesis of revised 88.  The revised structure was arisen from their biosynthetic 
hypothesis of photochemical, conrotatory 6π elctrocycloaddition of hypothetical precursor 95. Suzuki 
coupling between vinylbromide 93 and borate 94 gave 95, which was applied to subsequent 
photochemical electrocyclization yielding desired 88. The authors noted not only the same NOE 
correlation between H9 and the 17-methyl group in 88 as described in the literature [45] but also a 
more intense NOE between 17-methyl/16-methyl and 17-methyl/H11 [47]. 
 
Scheme 9. Synthesis of proposed and revised tridachiahydropyrone. 
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Another example of the synthesis of 4’-chloroaurone 96, a bioactive metabolite from the marine 
brown alga Spatoglossum variabile [48], was achieved by Subbaraju as shown in Scheme 10.   
2-Hydroxyacetophenone (97) was reacted with 4-chlorobenzaldehyde under the basic condition to give 
chlorochalcone 98, which was then treated with mercury (II) acetate to afford the desired 96.  
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Scheme 10. Synthesis of proposed structures of 4’-chloroaurone. 
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Since the spectral data of 96 did not match with those of reported 4’-chloroaurone, Z-96 was then 
photoisomerized to thermodynamically more stable E-isomer  99. But 99 did not agree with   
4’-chloroaurone either. After careful analysis of the spectral data for natural 4’-chloroaurone, the 
authors found that the data agreed well with the reported data of known   
3-(4’-chlorophenyl)-isocoumarin (100) [49]. 
 
2.4. Our Experiences with Pericosines 
 
The isolation of pericosines A and B as cytotoxic metabolites of the fungus Periconia byssoides 
OUPS-N133 originally separated from the sea hare Aplysia kurodai was reported in 1997 [50].
 As the 
absolute configuration of pericosine A was not determined, we performed the total synthesis of the 
originally proposed structure of pericosine A 101 as shown in Scheme 11 (Equation 1). Known lactone 
102 derived from (-)-quinic acid was chlorinated to chloroketone 103 in a stereoselective manner. 
Conversion of 103 to 101 was achieved via intermediate 104 and we found that 101 was incorrect 
structure of pericosine A [4,5]. In 2006, we reported the first total synthesis of the antipode of revised 
pericosine A (-)-105 and established its absolute configuration [6]. Revised structure 105 was 
presented after detailed analysis of NMR data for the natural product and several synthesized 
compounds related to pericosines. Total synthesis of 105 starting from (-)-shikimic acid involved a 
stereoselective dihydroxylation with catalytic osmiumtetroxide and trimethyamine-N-oxide yielding 
106 and a stereoselective induction of chlor atom against alcohol 107 as shown in Scheme 11   
(Equation 2). Since the synthesized 105 showed identical spectral data to natural pericosine A except 
for the sign of specific rotation, it was proved to be antipode of the natural product. The following year, 
we synthesized the natural form (+)-105 [7].  
In 2007, a full account of the isolation and structure elucidation of pericosines A-E was reported by 
the original researchers [51]. In that paper, the structure of pericosine A was revised based on our 
synthesis and new compound pericosine D 108 was reported. The following year, we synthesized 26 
from chlorohydrine 109 that was obtained as a minor product of the ring opening reaction with 
hydrogen chloride of epoxide 110 derived from (-)-quinic acid via unstable diene 111, and elucidated 
the absolute configuration of natural 108 [52] by a synthetic approach, as shown in Scheme 11 
(Equation 3). We also revised the spectral data of the natural product because synthesized 108 
possessing the proposed structure showed different spectral data from the natural product [51].   Mar. Drugs 2009, 7                                    
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We concluded that the originally reported pericosine D must have a different relative configuration 
from the reported acetonide, which had relative stereochemistry corresponding to 108. After 
completing the synthesis of (-)-pericosine B [53] and the improved synthesis of (+)-pericosine A 105 
and C [54], we will undertake the new challenge of elucidating the correct structure of originally 
reported pericosine D. 
 
Scheme 11. Synthesis of pericosines. 
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3. Summary 
 
In our review of the literature that has appeared in the last couple of years, we can witness 
numerous examples of misassignments of structures of marine natural products. Clearly, we still have 
much to learn about marine natural products possessing unusual structural features. We saw what 
synthetic chemists had to go through to overcome such formidable situations. Each and every total 
synthesis is extremely high level work. We recognized again the importance of synthetic studies for 
structure elucidation, as well as the need to supply marine-derived materials or to chemically modify 
molecules to increase pharmacological activity, in the development of marine-derived drugs. 
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